DUBLIN, Feb. 12, 2024 /PRNewswire/ -- The "Pharmaceutical Industry in South Africa 2023" report has been added to
ResearchAndMarkets.com's offering.
More than 80% of South African pharmaceutical manufacturing and distribution revenue is from the private sector. State purchases of pharmaceuticals are declining, and manufacturers' margins are under pressure due to low regulated price increases for scheduled pharmaceuticals in a high inflation environment.
In the retail sector Clicks and Dis-Chem have wholesale volume advantages and an ever-increasing footprint. Consumer spending patterns have forced consolidation in the retail sector, the growth of private label sales, growth in convenience formats, and diversification into new services and products. There has been a flurry of investments in localising vaccine raw material and finished dose manufacturing, although the sustainability of these initiatives is far from secure.
Cannabis cultivation, processing and medical product manufacturing
Rapid growth in generic sales making medicine more affordable
Strong R&D and advanced manufacturing capabilities may attract investment
Growing concentration of wholesale and retail pharmacy supply.
Low regulated medicine price increases in the context of high international inflation.
Poor economic growth constraining consumer spending on healthcare.
Reduced government budgets for medicines restricting local opportunities in the face of cheaper international competition.
South Africa's dependence on imported active ingredients. Sustaining local vaccine manufacturing in the face of declining demand.
A shift from reactive medicine to preventative healthcare resulting in demand for immunity-building vitamins, tonics, minerals and supplements.
Growing pressure on pharmaceutical companies to improve access to healthcare by making medicines more affordable.
Increased focus on localisation, including local sourcing of inputs and the development of local manufacturing capacity.
Recovery of demand as elective surgery and procedures and illnesses such as flu return to pre-pandemic patterns. Small community pharmacies are finding it difficult to compete with large retail businesses.
The pharmaceutical industry is well developed and supported by strong R&D and advanced manufacturing capabilities, including biotechnology manufacturing facilities. The Department of Health's affordable medicines programme has been instrumental in lowering scheduled pharmaceutical prices, particularly in the public sector. Investments in vaccine manufacture have begun to address South Africa's exposure to vulnerabilities and dependence on active pharmaceutical ingredient and vaccine imports. These investments have strengthened South Africa's position as the hub for sub-Saharan African pharmaceutical research, development, and supply.
However, vaccine demand has dropped and doses are being donated to African countries. Margin pressure is expected to grow as the economy remains poor and restraints on consumer spending intensify. The implementation of the National Health Insurance is likely to put further pressure on manufacturers and wholesalers to reduce medicine prices.
This report on the pharmaceutical industry in South Africa provides comprehensive information on the manufacturing, wholesale and retail subsectors, price regulation, medical cannabis, market shares, notable multinational and local players and corporate actions.
Acino Healthcare Group (Pty) Ltd
African Medicines (Pty) Ltd
Amway South Africa (Pty) Ltd
Arrie Nel Pharmacy Group (Pty) Ltd
Astellas Pharma (Pty) Ltd
AstraZeneca Pharmaceuticals (Pty) Ltd
Barrs Pharmaceuticals Industries (Pty) Ltd
Baxter Healthcare South Africa (Pty) Ltd
Bio Earth Manufacturing (Pty) Ltd
Biologicals and Vaccines Institute of Southern Africa (Pty) Ltd (The)
Bitek Industries (Pty) Ltd
California Pharmaceuticals (Pty) Ltd
Chemical Convertors (Pty) Ltd
Chemtron Holdings (Pty) Ltd
Cilo Cybin Pharmaceutical (Pty) Ltd
Columbia Pharmaceuticals (Pty) Ltd
Dr Reddy's Laboratories (Pty) Ltd
Forever Living Products South Africa (Pty) Ltd
Fresenius Kabi Manufacturing SA (Pty) Ltd
G M Pharmaceuticals (Pty) Ltd
Glenmark Pharmaceuticals South Africa (Pty) Ltd
Goodleaf Company (Pty) Ltd (The)
Gulf Drug Company (Pty) Ltd
Herbalife International South Africa Ltd
Hersol Manufacturing Laboratories (Pty) Ltd
IMBC Investment (Pty) Ltd
iMvula Healthcare Logistics (Pty) Ltd
Infection Protection Products (Pty) Ltd
Ingelheim Pharmaceuticals (Pty) Ltd
Iszipharm Pharmaceutical Distributors (Pty) Ltd
Johnson and Johnson (Pty) Ltd
Kellogg Company of South Africa (Pty) Ltd
Leaf Botanicals (Pty) Ltd
NeoLife International (Pty) Ltd
Nestle (South Africa) (Pty) Ltd
Netcare Pharmacies (Pty) Ltd
Netcare Pharmacies 2 (Pty) Ltd
New Clicks South Africa (Pty) Ltd
Novartis South Africa (Pty) Ltd
Organon South Africa (Pty) Ltd
P and G South African Trading (Pty) Ltd
Pharmaceutical Enterprises (Pty) Ltd
Pharmacy Direct (Pty) Ltd
Pharmacyweb Holdings (Pty) Ltd
Pharmed Pharmaceuticals (Pty) Ltd
Prime Cleaning Suppliers (Pty) Ltd
Reckitt Benckiser Pharmaceuticals (Pty) Ltd
Releaf Pharmaceuticals (Pty) Ltd
S A Natural Products (Pty) Ltd
Safety Chemicals (Pty) Ltd
Sandoz South Africa (Pty) Ltd
Sanofi Industries South Africa (Pty) Ltd
Solgar South Africa (Pty) Ltd
Specialised Maintenance Products (Pty) Ltd
Topmed Health Care Distributors (Pty) Ltd
Touchless Germ Control Western Cape CC
Viatris South Africa (Pty) Ltd
Wellness Warehouse (Pty) Ltd
For more information about this report visit https://www.researchandmarkets.com/r/e341vv
About ResearchAndMarkets.com
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
Laura Wood, Senior Manager
For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Fax (outside U.S.): +353-1-481-1716
Logo: https://mma.prnewswire.com/media/539438/Research_and_Markets_Logo.jpg
SOURCE Research and Markets